- Home
- TIL vs NVX Comparison
TIL vs NVX Comparison
Compare TIL & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- NVX
- Stock Information
- Founded
- TIL 2018
- NVX 2012
- Country
- TIL United States
- NVX Australia
- Employees
- TIL N/A
- NVX N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- NVX Industrial Machinery/Components
- Sector
- TIL Health Care
- NVX Miscellaneous
- Exchange
- TIL Nasdaq
- NVX Nasdaq
- Market Cap
- TIL 171.7M
- NVX 169.3M
- IPO Year
- TIL 2021
- NVX N/A
- Fundamental
- Price
- TIL $26.95
- NVX $1.13
- Analyst Decision
- TIL Buy
- NVX
- Analyst Count
- TIL 5
- NVX 0
- Target Price
- TIL $119.00
- NVX N/A
- AVG Volume (30 Days)
- TIL 316.4K
- NVX 95.0K
- Earning Date
- TIL 05-13-2025
- NVX 01-01-0001
- Dividend Yield
- TIL N/A
- NVX N/A
- EPS Growth
- TIL N/A
- NVX N/A
- EPS
- TIL N/A
- NVX N/A
- Revenue
- TIL N/A
- NVX $5,854,424.00
- Revenue This Year
- TIL N/A
- NVX $66.66
- Revenue Next Year
- TIL N/A
- NVX $2,366.64
- P/E Ratio
- TIL N/A
- NVX N/A
- Revenue Growth
- TIL N/A
- NVX N/A
- 52 Week Low
- TIL $9.62
- NVX $0.81
- 52 Week High
- TIL $92.00
- NVX $2.73
- Technical
- Relative Strength Index (RSI)
- TIL 65.08
- NVX 42.20
- Support Level
- TIL $12.60
- NVX $1.15
- Resistance Level
- TIL $35.28
- NVX $1.42
- Average True Range (ATR)
- TIL 3.84
- NVX 0.10
- MACD
- TIL 1.60
- NVX -0.03
- Stochastic Oscillator
- TIL 63.27
- NVX 0.00
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.